Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
ABSI Stock | USD 4.38 0.36 8.96% |
Under 52% of Absci Corp's investor base is interested to short. The analysis of the overall investor sentiment regarding Absci Corp suggests that many traders are impartial. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
VANCOUVER, Wash., Aug. 10, 2023 Absci Corporation , a generative AI drug creation company, today announced that leading researchers at the California Institute of Technology in conjunction with Absci, a leader in AI drug creation, received a grant from the Bill Melinda Gates Foundation. The grant supports the joint effort of Caltech and Absci to discover affordable HIV therapeutic vaccinations, with the goal of making a significant step forward in th
Read at finance.yahoo.com
Absci Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Absci Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Absci Corp is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
XFOR | X4 Pharmaceuticals | 14.24 | ||||
RLAY | Relay Therapeutics | 12.42 | ||||
RXRX | Recursion Pharmaceuticals | 1.47 | ||||
ABOS | Acumen Pharmaceuticals | 0.92 | ||||
INZY | Inozyme Pharma | 0.34 | ||||
CRBU | Caribou Biosciences | 0.49 | ||||
DAWN | Day One | 0.61 | ||||
AFMD | Affimed NV | 2.59 | ||||
DTIL | Precision BioSciences | 2.96 | ||||
ELEV | Elevation Oncology | 4.00 | ||||
SANA | Sana Biotechnology | 5.65 | ||||
HEPA | Hepion Pharmaceuticals | 7.16 | ||||
ZURA | Zura Bio | 9.71 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |